Navigation Links
Particle Sciences and HORIBA Instruments Form Strategic Relationship
Date:2/7/2011

BETHLEHEM, Pa., Feb. 7, 2011 /PRNewswire/ -- Particle Sciences, Inc., a leading pharmaceutical CRO, is pleased to announce the establishment of a strategic alliance with HORIBA Instruments of Irvine, CA, which is the U.S. sales and marketing division of HORIBA Limited of Kyoto, Japan.  This alliance assures that both client bases are provided with a total solution, combining the most up-to-date physical characterization tools with operational expertise in a fully GLP/GMP compliant setting.

Under the arrangement, the full array of HORIBA characterization tools will be available at Particle Sciences.  Dr. Robert Lee, Vice President of Pharmaceutical Development at Particle Sciences states, "The need for particle size analysis and physical characterization in general is growing rapidly within this highly regulated environment.  Particle Sciences is a world leader in particulate formulations and drug/device combination products.  We looked for a partner that shared the same commitment to quality and innovation and HORIBA fit the bill."

With this in place, HORIBA clients will have a resource that can both develop and perform characterization under cGLPs and cGMPs.  According to Dr. Mike Pohl, HORIBA's Vice President, "Our client base ranges from startups to the largest multinational Pharma and Biotech companies.  For a variety of reasons, we are often asked if we can recommend a site familiar with pharmaceutical development at which they could have work performed.  We have worked with Particle Sciences for some time and have been impressed with their facility and their team.  By entering into this relationship, we can ensure that our clients not only gain access to the most advanced technology, but also that the operators are highly trained to use the instruments to their fullest capability."

Dr. Lee adds, "Particle Sciences is committed to remaining one of the premier drug delivery development services providers.  We offer a broad array of drug delivery technologies and routinely work on atypical dosage forms.  It's critical that our analytic and characterization capabilities keep pace with our formulation expertise.  Additionally, as our clients scale to clinical and ultimately commercial processes, we need to ensure the methods we develop are phase appropriate and based on readily available techniques.  HORIBA is the world's largest instrument manufacturer with the most complete product offering and can now provide the level of security our clients deserve."

Dr. Pohl asserts, "Many pharmaceutical customers are located along the East Coast.  The combination of our Edison, NJ headquarters plus the Bethlehem, PA location of Particle Sciences, Inc., gives HORIBA a strong one-two punch to support these customers.  Services ranging from sample analysis, customer support, and full consulting services will now be readily accessible to our customers."

The HORIBA Group of worldwide companies provides an extensive array of instruments and systems for applications ranging from automotive R&D, process and environmental monitoring, in-vitro medical diagnostics, semiconductor manufacturing and metrology, to a broad range of scientific R&D and QC measurements. Proven quality and trustworthy performance have established widespread confidence in the HORIBA Brand.  

Particle Sciences is an integrated provider of drug development services.  Particle Sciences has deep expertise in micro and nano-particulate drug delivery technologies and drug/device combination products with additional specialized capabilities in topical and mucosal drug products.  Through a full range of formulation, analytic, and manufacturing services, Particle Sciences provides pharmaceutical companies with a complete and seamless development solution that minimizes the time and risk between discovery and the clinic.  The company was founded in 1991 and is headquartered in Bethlehem, Pennsylvania.  Visit www.particlesciences.com, email info@particlesciences.com or contact us at (610) 861- 4701 for information.Contact: Maureen Cochran610-861-4701mcochran@particlesciences.com
'/>"/>

SOURCE Particle Sciences Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. NC State engineers discover nanoparticles can break on through
2. Particle Sciences sells T-COTE(R) Line of Microfine Titanium Dioxides to Sensient
3. Engineering nanoparticles for maximum strength
4. Altogen Biosystems Launches New Nanoparticle-based In Vivo Transfection Reagent
5. MonoSol Rx and Midatech Group Enter Collaboration Agreement to Unite Nanoparticle and Thin Film Drug Delivery Technologies
6. RVX-208 Data Demonstrates Increase in Functional HDL Particles
7. Surface plasmon resonances of metal nanoparticles in array can have narrower spectral widths
8. Enhancing solar cells with nanoparticles
9. Novavax and Vivalis Sign a Research License Agreement to Use the EB66(R) Cell Line for the Production of Virus Like Particle Based Vaccines
10. Nanoparticles double their chances of getting into sticky situations
11. Gold-palladium nanoparticles achieve greener, smarter production of hydrogen peroxide
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/2/2016)... ... December 02, 2016 , ... Robots will storm the Prudential Center in ... 2016. The event, which is held on the United Nations International Day of Persons ... back into the workplace. Suitable Technologies is partnering with NTI to showcase how technology ...
(Date:11/30/2016)... , ... November 30, 2016 , ... ... moving magnet Voice Coil Actuator with a flexure design that ensures high alignment ... with cost-effective pricing and is ideally suited where extreme precision is required, such ...
(Date:11/30/2016)... 30, 2016 Biotest Pharmaceuticals Corporation (BPC), a ... announce the addition of its newest plasma collection center ... . The 15,200 square foot state-of-the-art facility officially ... and brings the total number of BPC,s plasma collection ... , BPC,s Chief Executive Officer said "We are pleased ...
(Date:11/30/2016)... DIEGO and BEIJING , ... a leading commercial provider of genomic services and solutions ... announced today that it has completed a USD $75 ... Merchants Bank Co., Ltd.,s CMB International Capital Management ( ... Innovation Investment Management Co., Ltd. ("SDIC Innovation") and Shanghai ...
Breaking Biology Technology:
(Date:11/22/2016)... November 22, 2016 According to the new market ... Print, Face, Vein, Signature, Voice), Multi-Factor), Component (Hardware and Software), Function (Contact ... MarketsandMarkets, the market is expected to grow from USD 10.74 Billion in ... 16.79% between 2016 and 2022. Continue Reading ... ...
(Date:11/21/2016)... , Nov. 21, 2016   Neurotechnology ... object recognition technologies, today announced that the MegaMatcher ... cards was submitted for the NIST Minutiae ... passed all the mandatory steps of the evaluation ... is a continuing test of fingerprint templates used ...
(Date:11/17/2016)... -- Global Market Watch: Primarily supported by ownership ... and Academics) market is to witness a value of US$37.1 ... highest Compounded Annual Growth Rate (CAGR) of 10.75% is foreseen ... period 2014-2020. North America is not ... Europe at 9.56% respectively. Report Focus: ...
Breaking Biology News(10 mins):